Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration.
Br J Ophthalmol
; 93(3): 305-9, 2009 Mar.
Article
in En
| MEDLINE
| ID: mdl-19019935
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Strontium Radioisotopes
/
Radiopharmaceuticals
/
Choroidal Neovascularization
/
Angiogenesis Inhibitors
/
Macular Degeneration
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Ophthalmol
Year:
2009
Document type:
Article
Affiliation country:
Brazil
Country of publication:
United kingdom